1. 1. Yang V, Gouveia MJ, Santos J, Koksch B, Amorim I, Gärtner F, Vale N (2020) Breast cancer: insights in disease and influence of drug methotrexate. RSC Medicinal Chemistry, 11(6):646-664. [DOI:10.1039/D0MD00051E]

2. Basu P and Maier C (2018) Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives. Biomedecine & Pharmacotherapie, 107:1648-1666. [DOI:10.1016/j.biopha.2018.08.100]

3. Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F, Jemal A, et al (2016) Cancer statistics in China, 2015. CA: a cancer journal for clinicians, 66(2): 115-132. [DOI:10.3322/caac.21338]

4. Fan L, Strasser-Weippl K, Li J, St Louis J, Finkelstein D, Yu K, Chen W, et al. (2014) Breast cancer in China. The Lancet Oncology, 15(7): e279-e289. [DOI:10.1016/S1470-2045(13)70567-9]

5. Sauter ER (2018) Breast Cancer Prevention: Current Approaches and Future Directions. Eur J Breast Health, 14(2): 64-71. [DOI:10.5152/ejbh.2018.3978]

6. Sequeira M, Luz R, Alvarez MJ (2022) The Practice of Physical Activity After Breast Cancer Treatments: A Qualitative Study Among Portuguese Women. Front Psychol, 2022, 13: 823139. [DOI:10.3389/fpsyg.2022.823139]

7. He H, Zhang G, Zhou H, Lin C, Xu Q, Liu R, Yu B, et al (2022) Differential Efficacy of B-Ultrasound Combined with Molybdenum Target Detection Mode for Breast Cancer Staging and Correlation of Blood Flow Parameters with IGF-1 and IGF-2 Expression Level and Prognosis. Contrast Media Mol Imaging, 2022: 9198626. [DOI:10.1155/2022/9198626]

8. Van-Baelen K, Geukens T, Maetens M, Tjan-Heijnen V, Lord CJ, Linn S, Bidard FC, et al. (2022) Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer. Ann Oncol, 33(8):769-785. [DOI:10.1016/j.annonc.2022.05.006]

9. Trinh L, Ikeda DM, Miyake KK, Trinh J, Lee KK, Dave H, Lipson J, et al (2019) Challenges in MRI detection of breast cancer: MRI features of benign and malignant conditions of the breast. Am J Roentgenol, 213(2): 269-276.

10. Mann RM, Cho N, Moy L (2019) Breast MRI: State of the Art. Radiology, 292(3): 520-536. [DOI:10.1148/radiol.2019182947]

11. Zhang L, Tang M, Min Z, Lu J, Lei X, Zhang X (2020) Multimodal 3-Dimensional Deep Learning for Automated Breast Tumor Detection and Classification Using Whole MR Volumes. Invest Radiol, 55(6): 363-372.

12. Agarwal S, Sharma U, Mathur S, Seenu V, Parshad R, Jagannathan NR (2018) Quantitative characterization of breast tissues using fast scan magnetic resonance spectroscopic imaging at 3T. Magn Reson Imaging, 50: 49-55. [DOI:10.1016/j.mri.2018.02.004]

13. Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, Hricak H, et al (2018) Background, Incidence, and Predictors of Anti-VEGF Therapy-Induced Complications in Breast Cancer: A Systematic Review and Meta-analysis. Radiology, 286(2): 471-482.

14. Gubern-Mérida A, Martí R, Melendez J, Hauth JLM, Mann RM, Karssemeijer N, Platel B (2016) Automated localization of breast cancer in DCE-MRI. Med Image Anal, 31: 46-57.

15. Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, Lazar AJ, et al (2020) WHO Classification of Tumours Editorial Board. The 2019 World Health Organization classification of tumours of the breast. Histopathology, 77(2):181-185. [DOI:10.1111/his.14091]

16. Aiello M, Cavaliere C, D'Alise AM, D'Amico P, Basso G, Salvatore M, Avallone A, et al (2018) A fully automatic approach in breast cancer diagnosis from MRI images: Clinical validation. Journal of Digital Imaging, 31(6): 896-904.

17. Bahrami N, Hartman SJ, Chang YH, Naranjo A, Meric-Bernstam F, Buchholz TA, Woodward W, et al (2019) Predictive value of dynamic contrast-enhanced magnetic resonance imaging during neoadjuvant chemotherapy for breast cancer. Oncotarget, 10(58): 6189-6199.

18. Grimm LJ, Zhang J, Baker JA, Soo MS, Johnson KS, Mazurowski MA (2018) Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype. Breast Journal, 24(5): 715-718. [DOI:10.1111/tbj.12799]

19. Onishi N, Kanao S, Kataoka M, Iima M, Sakaguchi R, Kawai M, Kataoka TR, et al (2019) Apparent diffusion coefficient as a potential surrogate marker for Ki-67 index in mucinous breast carcinoma. Journal of Magnetic Resonance Imaging, 49(4): 1180-1186.

20. Preibsch H, Wanner L, Bahrs SD, Wietek BM, Siegmann-Luz KC, Oberlecher E, Hahn M, et al (2017) Size matters: The influence of training on qualitative lesion characterization with breast MRI. European Radiology, 27(5): 1940-1947.

21. Agarwal S, Sharma U, Mathur S, Seenu V, Parshad R, Jagannathan NR (2021) Role of textural features in the differential diagnosis of malignant and benign breast lesions on DCE-MRI. Magnetic Resonance Imaging, 76: 49-58.

22. Drukker K, Giger ML, Joe BN, Kerlikowske K, Greenwood H, Drukteinis JS, Niell B, et al (2019) Combined Benefit of Quantitative Three-Compartment Breast Image Analysis and Mammography Radiomics in the Classification of Breast Masses in a Clinical Data Set. Radiology, 290(3): 621-628. [DOI:10.1148/radiol.2018180608]

23. Thompson JL, Wright GP (2021) The role of breast MRI in newly diagnosed breast cancer: An evidence-based review. Am J Surg, 221(3):525-528. [DOI:10.1016/j.amjsurg.2020.12.018]

24. Choi JS (2023) Breast Imaging Reporting and Data System (BI-RADS): Advantages and Limitations. J Korean Soc Radiol, 84(1): 3-14. [DOI:10.3348/jksr.2022.0142]

25. Spak DA, Plaxco JS, Santiago L, Dryden MJ, Dogan BE (2017) BI-RADS® fifth edition: A summary of changes. Diagn Interv Imaging, 98(3): 179-190. [DOI:10.1016/j.diii.2017.01.001]

26. Han M, Kim TH, Kang DK, Kim KS, Yim H (2012) Prognostic role of MRI enhancement features in patients with breast cancer: value of adjacent vessel signs and increased ipsilateral whole-breast vascularity. AJR Am J Roentgenol, 2012,199(4): 921-928. [DOI:10.2214/AJR.11.7895]

27. Rauch GM, Adrada BE (2018) Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation. Magn Reson Imaging Clin N Am, 26(2):273-280. [DOI:10.1016/j.mric.2017.12.009]

28. Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci, 77(9): 1745-1770. [DOI:10.1007/s00018-019-03351-7]

29. Majidpoor J, Mortezaee K (2021) Angiogenesis as a hallmark of solid tumors - clinical perspectives. Cell Oncol (Dordr), 44(4):715-737. [DOI:10.1007/s13402-021-00602-3]

30. Penault-Llorca F, Radosevic-Robin N (2017) Ki67 assessment in breast cancer: an update. Pathology, 2017, 49(2): 166-171. [DOI:10.1016/j.pathol.2016.11.006]